104 Chapter 5 Isolate Treatment regimen/ duration MIC/ susceptibility resistance genes DX MIC/ susceptibility resistance genes VA Disk zone/ susceptibility resistance genes TR tet(K) - - 2223 SXT RA MP / 7 ≤ 1.0 / S 1 / S 25 / S - - - 2392 CL RA MP / 14 ≤ 1.0 / S ≤ 0.5 / S 21 / S - - - 302760 CL RA MP / 7 ≤ 1.0 / S 1 / S 6 / R - - - 2879 TR RA MP / 7 ≤ 1.0 / S 1 / S 23 / S - - - 3260 DX RA MP / 7 ≤ 1.0 / S 1 / S 22 / S - - - 3488 CL RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S 19 / S - - - 3839 TR RA MP / 7 ≥ 16.0 / R 1 / S 19 / S tet(K) - - 4998 DX RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S 19 / S - - - 5308 DX RA MP / 7 ≤ 1.0 / S 1 / S 21 / S - - - 6826 DX RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S 23 / S - - - 7211 SXT RA MP / 14 ≥ 16.0 / R ≤ 0.5 / S - / S tet(K) - - 7261 SXT RA MP / 7 ≥ 16.0 / R ≤ 0.5 / S 25 / S tet(K) - - 7450 TR RA MP / 7 ≤ 1.0 / S ≤ 0.5 / S 22 / S - - - 8178 SXT RA MP / 7 ≥ 16.0 / R 1 / S 21 / S tet(K) - - 8244 VA CL MP / 7 ≤ 1.0 / S 1 / S 22 / S - - - 8935 SXT RA MP / 7 ≥ 16.0 / R 1 / S 21 / S tet(K) - - Legend: Treatment duration is in days. MIC is in mg/L. Disc zone is in millimetres. VA: vancomycin, RA: rifampicin, CL: clindamycin, MP: mupirocin. S/I/R: susceptible/intermediate/resistant.
RkJQdWJsaXNoZXIy MTk4NDMw